Page last updated: 2024-09-04

lonafarnib and Cell Transformation, Neoplastic

lonafarnib has been researched along with Cell Transformation, Neoplastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lowe, SW; Mavrakis, KJ; Mills, JR; Pelletier, J; Silva, RL; Tam, W; Teruya-Feldstein, J; Wendel, HG; Zhu, H1

Other Studies

1 other study(ies) available for lonafarnib and Cell Transformation, Neoplastic

ArticleYear
Tumorigenic activity and therapeutic inhibition of Rheb GTPase.
    Genes & development, 2008, Aug-15, Volume: 22, Issue:16

    Topics: Animals; Antibiotics, Antineoplastic; Blotting, Western; Cell Transformation, Neoplastic; Cells, Cultured; Cellular Senescence; Doxorubicin; Eukaryotic Initiation Factor-4E; Farnesyltranstransferase; Female; Fibroblasts; Gene Dosage; Humans; Immunophenotyping; Immunosuppressive Agents; Lymphoma; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Knockout; Monomeric GTP-Binding Proteins; Multiprotein Complexes; Neuropeptides; Phosphorylation; Piperidines; Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; PTEN Phosphohydrolase; Pyridines; Ras Homolog Enriched in Brain Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Transcription Factors; Tumor Suppressor Protein p53

2008